• Publications
  • Influence
Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults.
Naltrexone/bupropion ER (Contrave): newly approved treatment option for chronic weight management in obese adults.
The discovery and status of sibutramine as an anti-obesity drug.
Sibutramine is one of the few established and well-proven agents for obesity available for use today and should be considered effective in the management of patients requiring pharmacotherapy as part of the multi-modal approach to weight-loss. Expand
Sibutramine: A Serotonin–Norepinephrine Reuptake-Inhibitor for the Treatment of Obesity
Based on anorectic efficacy data, sibutramine, a serotonin–norepinephrine reuptake-inhibitor, is a viable therapeutic option for the treatment of obesity. Expand
Tetrabenazine (Xenazine), An FDA-Approved Treatment Option For Huntington's Disease-Related Chorea.
  • T. Yero, J. Rey
  • Medicine
  • P & T : a peer-reviewed journal for formulary…
  • 1 December 2008
Tetrabenazine has been used for decades in several countries to treat chorea and other hyperkinetic movement disorders, such as dystonias and tics and is provided a concise review of the pharmacology, pharmacokinetics, safety, and efficacy of this much needed treatment option to ameliorate some of the disabling symptoms of HD. Expand
Brexpiprazole (Rexulti): A New Monotherapy for Schizophrenia and Adjunctive Therapy for Major Depressive Disorder.
Brexpiprazole (Rexulti): a new monotherapy for schizophrenia and adjunctive therapy for major depressive disorder.
Cognitive and Performance Enhancing Medication Use to Improve Performance in Poker
Unmonitored use of pharmacologically active agents and their methods of acquisition highlight safety concerns in this cohort of poker players, especially among non-professional players. Expand
Vortioxetine (brintellix): a new serotonergic antidepressant.
Vortioxetine (Brintellix): a new serotonergic antidepressant that acts as a ‘spatially aggregating force’ to serotonin in the brain to treat depression and anxiety. Expand
Atypical Antipsychotics in Children with Pervasive Developmental Disorders
R risperidone has the largest amount of evidence, and should be considered an appropriate therapeutic option, as part of a comprehensive treatment strategy, for children with PDD, and ziprasidone and aripiprazole appear to be promising treatment options. Expand
Prevalence of hazardous alcohol use among pharmacy students at nine U.S. schools of pharmacy
Levels of alcohol consumption and estimate the level of hazardous drinking among pharmacy students in a larger sample size that is representative of US pharmacy schools indicate that over one-fourth of pharmacy students surveyed have indicators of harmful alcohol use. Expand
Invega Trinza: The First Four-Times-a-Year, Long-Acting Injectable Antipsychotic Agent.
Paliperidone palmitate three-month injection (Invega Trinza): the first four-times-a-year, long-acting injectable antipsychotic agent for schizophrenia.